Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they’re needed. As a proof of concept, the researchers filled the nanoparticles with the drug dexamethasone and administered them to mice with inflamed lung tissue. Inflammation was completely treated in mice given the nanoparticles, at a drug concentration where standard delivery methods did not have any efficacy.
New research finds that quitting smoking is an effective way to resolve impaired lung function and airway inflammation associated with waterpipe smoking. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology.
Article title: Bacterial extracellular vesicles isolated from organic dust induce neutrophilic inflammation in the lung Authors: Velmurugan Meganathan, Regina Moyana, Kartiga Natarajan, Weshely Kujur, Shilpa Kusampudi, Sachin Mulik, Vijay Boggaram From the authors: “In summary, our studies have found that…
Vaping-associated lung injury is a condition characterized by lung inflammation and damage that can lead to respiratory failure and death. Symptoms include shortness of breath, cough, and chest pain, as well as fatigue, fever, and weight loss. Many patients report gastrointestinal symptoms too.
Healthcare experts are urging people to avoid vaping because the exact cause of vaping-associated lung injury is unknown.
People who are using vaping products — especially young people, who have been most frequently affected by the condition — should closely monitor their health and seek immediate medical care if they develop symptoms.